Literature DB >> 12700938

Bone metastases from osteosarcoma.

M San-Julian1, P Diaz-de-Rada, E Noain, L Sierrasesumaga.   

Abstract

Bony metastases in patients with osteosarcoma are unusual and normally appear late in the course of the disease. We report our experience with eight such patients, four with solitary and four with multiple metastases. Those with solitary metastases were treated as new tumours with neoadjuvant chemotherapy and surgery. Three remain alive with no evidence of disease at 5, 7 and 8 years follow-up respectively. Histology and response to neoadjuvant chemotherapy was similar in both the primary and metastatic lesions and is a predictive factor of outcome. Those with multiple metastases were treated by palliative measures, and none survived. We conclude that resection of solitary metastases from osteosarcoma after neoadjuvant chemotherapy can be curative.

Entities:  

Mesh:

Year:  2002        PMID: 12700938     DOI: 10.1007/s00264-002-0407-8

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  7 in total

1.  Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma.

Authors:  Byung Hyun Byun; Chang-Bae Kong; Ilhan Lim; Byung Il Kim; Chang Woon Choi; Won Seok Song; Wan Hyeong Cho; Dae-Geun Jeon; Jae-Soo Koh; Soo-Yong Lee; Sang Moo Lim
Journal:  Skeletal Radiol       Date:  2013-08-31       Impact factor: 2.199

2.  Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.

Authors:  Kehan Song; Jian Song; Kaiyuan Lin; Feiyan Chen; Xiaosheng Ma; Jianyuan Jiang; Feng Li
Journal:  Int Orthop       Date:  2019-05-24       Impact factor: 3.075

3.  Paracrine-mediated osteoclastogenesis by the osteosarcoma MG63 cell line: is RANKL/RANK signalling really important?

Authors:  J Costa-Rodrigues; C A Teixeira; M H Fernandes
Journal:  Clin Exp Metastasis       Date:  2011-04-09       Impact factor: 5.150

Review 4.  PET/MR of pediatric bone tumors: what the radiologist needs to know.

Authors:  Jennifer Padwal; Lucia Baratto; Amit Chakraborty; Kristina Hawk; Sheri Spunt; Raffi Avedian; Heike E Daldrup-Link
Journal:  Skeletal Radiol       Date:  2022-07-09       Impact factor: 2.199

5.  Three Metachronous Osteosarcomas within 22 Years without Pulmonary Metastases: A Case Report and Review of the Literature.

Authors:  Ulrike Michaela Pirker-Frühauf; Jörg Friesenbichler; Katharina Rabitsch; Bernadette Liegl-Atzwanger; Thomas Bauernhofer; Reinhard Windhager; Andreas Leithner
Journal:  Case Rep Orthop       Date:  2013-12-25

6.  Leptocarpin Suppresses Proliferation, Migration, and Invasion of Human Osteosarcoma by Targeting Type-1 Insulin-Like Growth Factor Receptor (IGF-1R).

Authors:  Shao-Wei Zheng; Wen-Guo Wan; Hai-Xiong Miao; Rui Tang; Bin Wang; Qi-Zhi Huang; Wei-le Liu; Jian-Ping Zheng; Chu-Qun Chen; Hao-Bo Zhong; Sheng-Fa Li; Chun-Han Sun
Journal:  Med Sci Monit       Date:  2017-08-27

7.  High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients.

Authors:  Anne J Schuster; Leo Kager; Peter Reichardt; Daniel Baumhoer; Monika Csóka; Stefanie Hecker-Nolting; Susanna Lang; Sylvie Lorenzen; Regine Mayer-Steinacker; Thekla von Kalle; Matthias Kevric; Mathias Werner; Reinhard Windhager; Thomas Wirth; Stefan S Bielack
Journal:  Sarcoma       Date:  2018-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.